Navigation Links
Director of Commerce, Rogers Weed, Presided Over Ribbon Cutting Ceremony Celebrating Opening of Expanded Manufacturing Facility at CMC Biologics

SEATTLE and COPENHAGEN, Denmark, Sept. 22, 2011 /PRNewswire/ -- CMC Biologics officially marked the opening of its state-of-the-art biopharmaceutical manufacturing facility, known as PF2, with a ribbon cutting ceremony on Wednesday, September 21, at its Bothell, Washington campus. The expansion of PF2 duplicates capacity and supports commercial manufacturing. Local political and business leaders attended the event.



Director of Commerce of Washington State, Rogers Weed, who presided over the dedication of the facility said, "I'm delighted to see Washington State's life sciences sector grow and expand. This region benefits in many ways from companies like CMC Biologics, which manufactures clinical and commercial materials for companies throughout the world. This is an industry that will provide the people of Washington State with jobs and prosperity into the next century."

According to David Kauffmann, Chairman of the Board of CMC Biologics and Managing Director of European Equity Partners, "Our vision has always been to be a global market leader in contract biopharmaceutical process development and manufacturing services. This facility expansion represents one more step toward making that vision a reality."

"We are proud of the positive impact of this project on the local economy. CMC Biologics used mainly local contractors for the expansion and once the facility is operating at full capacity, we anticipate adding about 35 new employees to staff it," noted Gustavo F. Mahler, Ph.D., Global Chief Operations Officer of CMC Biologics. "I'd like to thank our contractors as well as all of the employees at CMC Biologics who were instrumental in bringing this project in on time and on budget."

The expansion project was led by Yonkers Industries, with support from Sellen, BMWC Constructors, Holaday-Parks, and Precision Electric Group, as well as other subcontractors.

About CMC Biologics

CMC Biologics ( is a dedicated contract biopharmaceutical manufacturing and development organization with facilities in Copenhagen, Denmark and Seattle, Washington, USA. CMC Biologics specializes in custom services for scale up and cGMP manufacture of protein-based therapeutics for preclinical, clinical trials, and in-market production. The Company's fully integrated services includes cell line development using its proprietary CHEF1® system, process and formulation development, and comprehensive analytical testing. CMC Biologics has fully segregated microbial fermentation and mammalian cell culture suites and offers stirred tank and perfusion production processes.

SOURCE CMC Biologics
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Ikaria® CEO Daniel Tasse Elected to PhRMA Board of Directors
2. Preetha Reddy, Managing Director, Apollo Hospitals Invited to United Nations Summit on NCDs
3. Rod Wolford Joins LABSCO Board of Directors
4. Gentris Corporation Announces Changes to Board of Directors
5. PTCB Board of Governors Announces Executive Director/CEO Murer Corrigan to Leave Organization
6. Stereotaxis Board of Directors Reaffirms Commercialization Plans for Epoch™ and Odyssey™ Product Platforms
7. Valeant Pharmaceuticals Announces Resignation of Michael Van Every From Valeants Board of Directors
8. Hospira Expands Board of Directors
9. Tengion Appoints Diane Jorkasky, M.D., to its Board of Directors
10. David J. Illingworth Appointed to Board of Directors for Varian Medical Systems
11. Genelux Corporation Appoints Catherine J. Mackey, PhD to Board of Directors
Post Your Comments:
(Date:12/1/2015)... Germany , December 1, 2015 /PRNewswire/ ... leading global manufacturer of eye and gaze tracking solutions, ... SMI remote eye trackers as a component of its ... concussions, eye sight, and medical and performance issues in ... part of SMI,s mass-market-ready eye tracking platform, which is ...
(Date:12/1/2015)... 1, 2015 --> ... van Leeuwenhoek Hospital (NKI-AVL), among the world,s largest ... Leksell Gamma Knife® Icon™, the company,s latest generation ... --> --> With the ... treatments, Leksell Gamma Knife Icon offers greatly enhanced ...
(Date:12/1/2015)... Dec. 01, 2015 ... "Drug Delivery Technology Market 2015 - Forecast ... --> ) has announced the addition ... - Forecast to 2020" report to their ... ) has announced the addition of the ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... December 01, 2015 , ... Physicians’ Education Resource®, LLC ... today announced that the first annual School of Gastrointestinal Oncology™ (SOGO™) will be ... and treatment of gastrointestinal cancers are undergoing transformational change, providing oncologists with powerful ...
(Date:12/1/2015)... ... 2015 , ... Growth in medical payments per workers’ compensation claim in Louisiana ... and nonhospital care, according to a recent study by the Workers Compensation Research Institute ... found medical payments per claim with more than seven days of lost time continued ...
(Date:12/1/2015)... Illinois (PRWEB) , ... December 01, 2015 , ... ... and share medical images have been lifted as IMAGE Information Systems launches MED-TAB™ ... Society of North America Annual Meeting from November 29 to December 4, 2015. ...
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... ... , Visage Imaging Inc. (“Visage”), a wholly owned subsidiary of Pro Medicus Ltd. ... results enhancements at the Radiological Society of North America (RSNA) 2015 annual meeting ...
(Date:12/1/2015)... , ... December 01, 2015 , ... ... solutions for the care management and population health arenas, is pleased to announce ... and cost containment services, has successfully implemented the ACUITY Complete Care™ Management to ...
Breaking Medicine News(10 mins):